114 related articles for article (PubMed ID: 31264550)
1. Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A Hypothesis.
Kazemi K; Mozafari N; Ashrafi H; Rafiei P; Azadi A
Curr Drug Discov Technol; 2020; 17(5):616-618. PubMed ID: 31264550
[TBL] [Abstract][Full Text] [Related]
2. Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma.
Zhu X; Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Liu H; He S
Oncol Rep; 2017 Jan; 37(1):622-630. PubMed ID: 27840970
[TBL] [Abstract][Full Text] [Related]
3. Casein Kinase 2 Interacting Protein-1 Suppresses Glioma Cell Proliferation via Regulating the AKT/GSK3
Xi YG; Ren DP; Jin JY; Zhu L; Yi TL; Shao XF; Sun SK; Zhang WB; Cheng SX
Biomed Res Int; 2019; 2019():5653212. PubMed ID: 31355268
[TBL] [Abstract][Full Text] [Related]
4. DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Wang Y; Cheng C
Leuk Res; 2016 Nov; 50():104-111. PubMed ID: 27701018
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
[TBL] [Abstract][Full Text] [Related]
6. Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.
Wu Y; Xu X; Miao X; Zhu X; Yin H; He Y; Li C; Liu Y; Chen Y; Lu X; Wang Y; He S
Cell Prolif; 2015 Dec; 48(6):682-90. PubMed ID: 26478515
[TBL] [Abstract][Full Text] [Related]
7. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
Tokuda E; Fujita N; Oh-hara T; Sato S; Kurata A; Katayama R; Itoh T; Takenawa T; Miyazono K; Tsuruo T
Cancer Res; 2007 Oct; 67(20):9666-76. PubMed ID: 17942896
[TBL] [Abstract][Full Text] [Related]
8. Rituximab (anti-CD20) selectively modifies Bcl-xL and apoptosis protease activating factor-1 (Apaf-1) expression and sensitizes human non-Hodgkin's lymphoma B cell lines to paclitaxel-induced apoptosis.
Jazirehi AR; Gan XH; De Vos S; Emmanouilides C; Bonavida B
Mol Cancer Ther; 2003 Nov; 2(11):1183-93. PubMed ID: 14617792
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
[TBL] [Abstract][Full Text] [Related]
10. Antitumor effects of Endostar on non-Hodgkin's lymphoma by regulating endothelial progenitor cells through protein kinase B-dependent pathway.
Yu D; Wu H; Yang B; Yang K; Liu H; Wu G
Acta Biochim Biophys Sin (Shanghai); 2013 Sep; 45(9):742-8. PubMed ID: 23811754
[TBL] [Abstract][Full Text] [Related]
11. The Role of the Pleckstrin Homology Domain-containing Protein CKIP-1 in Activation of p21-activated Kinase 1 (PAK1).
Kim YB; Shin YJ; Roy A; Kim JH
J Biol Chem; 2015 Aug; 290(34):21076-21085. PubMed ID: 26160174
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
13. CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo.
Deng M; Shi Y; Chen K; Zhao H; Wang Y; Xie S; Zhao J; Luo Y; Fang Z; Fan Y; Xu B
Exp Cell Res; 2018 Aug; 369(2):356-362. PubMed ID: 29864401
[TBL] [Abstract][Full Text] [Related]
14. Casein kinase 2 interacting protein 1 positively regulates caudal-related homeobox 1 in intestinal-type gastric cancer.
Ma L; Cao Y; Hu JJ; Chu ML
Chin Med J (Engl); 2020 Jan; 133(2):154-164. PubMed ID: 31868807
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibited the MIP-1α expression via inhibition of Ras/ERK and Ras/Akt pathways in myeloma cells.
Tsubaki M; Mashimo K; Takeda T; Kino T; Fujita A; Itoh T; Imano M; Sakaguchi K; Satou T; Nishida S
Biomed Pharmacother; 2016 Mar; 78():23-29. PubMed ID: 26898421
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention.
Jazirehi AR; Bonavida B
Oncogene; 2005 Mar; 24(13):2121-43. PubMed ID: 15789036
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.
Zhao Z; Zhang X; Wen L; Yi S; Hu J; Ruan J; Zhao F; Cui G; Fang J; Chen Y
Eur J Pharmacol; 2016 Oct; 789():46-59. PubMed ID: 27370960
[TBL] [Abstract][Full Text] [Related]
18. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
19. CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation.
Nie J; Liu L; Xing G; Zhang M; Wei R; Guo M; Li X; Xie P; Li L; He F; Han W; Zhang L
Oncogene; 2014 Jul; 33(28):3677-87. PubMed ID: 23995790
[TBL] [Abstract][Full Text] [Related]
20. Rituximab inhibits the constitutively activated PI3K-Akt pathway in B-NHL cell lines: involvement in chemosensitization to drug-induced apoptosis.
Suzuki E; Umezawa K; Bonavida B
Oncogene; 2007 Sep; 26(42):6184-93. PubMed ID: 17420722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
